Marketing-authorisation holder · Canada
Hls Therapeutics Inc
8 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLOZARIL200 mg · Tablet | Clozapine | Canada | Marketed | 2019 |
| CLOZARIL25 mg · Tablet | Clozapine | Canada | Marketed | 1991 |
| CLOZARIL100 mg · Tablet | Clozapine | Canada | Marketed | 1991 |
| CLOZARIL50 mg · Tablet | Clozapine | Canada | Marketed | 2019 |
| NILEMDO180 mg · Tablet | Bempedoic acid | Canada | Marketed | 2026 |
| VASCEPA1 G · Capsule | Icosapent ethyl | Canada | Marketed | 2020 |
| PERSERIS120 mg / syr · Kit, Powder For Suspension (Sustained-Release | Risperidone | Canada | Cancelled | 2021 |
| PERSERIS90 mg / syr · Kit, Powder For Suspension (Sustained-Release | Risperidone | Canada | Cancelled | 2021 |
Countries
Where it holds or makes medicines, with how many are current.